أرسل هذا في رسالة قصيرة: Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4⁺CD25⁺Foxp3⁺ and CD4⁺CD25⁻Foxp3⁺ T cells